Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients - Concepedia

Concepedia

Publication | Open Access

Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients

DOI Full Paper Access

18

Citations

108

References

2022

Year

Lena Peter, Désirée J. Wendering, Stephan Schlickeiser, Henrike Hoffmann, Rebecca Noster, Dimitrios L. Wagner, Ghazaleh Zarrinrad, Sandra Münch, Samira Picht, Sarah Schulenberg,

Molecular Therapy — Methods & Clinical Development

References

	Year	Citations

Page 1